Reneo Pharmaceuticals(RPHM) - 2025 Q4 - Annual Results

EXHIBIT 99.1 OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results -- Data from the ongoing PIKture-01 trial is expected to be announced in March 2026; continued enrollment in breast cancer triplet combinations -- Approximately $59M in cash and cash equivalents at the end of Q4 2025 BOULDER, CO, March 12, 2026 -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on developing novel precision medicines, today reported financial results for ...